BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs3825942
,
MDM2
,
T cell differentiation
,
Diabetes mellitus
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
type I interferon receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity…
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arcti…
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Association of IFNAR1 and IFNAR2 with COVID-19 severity.
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genetic and Biochemical Markers of Interferon-Induced Depression.
REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patie…
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High I…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ